Table 3.
Adverse events
Adverse events | Grade < 3, n (%) | Grades 3 or 4, n (%) |
---|---|---|
White blood cells decreased | 1 (3.3) | 0 |
Hypotension | 1 (3.3) | 0 |
Diarrhea | 6 (20) | 0 |
Anorexia | 1 (3.3) | 0 |
Nausea | 2 (6.7) | 0 |
Abdominal distention | 2 (6.7) | 0 |
Abdominal pain | 1 (3.3) | 0 |
Anal pain | 1 (3.3) | 0 |
Constipation | 1 (3.3) | 0 |
Hemorrhoids | 1 (3.3) | 0 |
Vomiting | 2 (6.7) | 0 |
Chills | 2 (6.7) | 0 |
Fatigue | 5 (16.7) | 0 |
Fever | 1 (3.3) | 0 |
Gram negative Bacilli | 1 (3.3) | 0 |
UTI | 1 (3.3) | 0 |
Localized shoulder edema | 1 (3.3) | 0 |
Insomnia | 2 (6.7) | 0 |
Dizziness | 1 (3.3) | 0 |
Vaginal discharge | 1 (3.3) | 0 |
Vulvar infection-herpes | 1 (3.3) | 0 |
Upper respiratory tract infection | 2 (6.7) | 0 |
Cough | 1 (3.3) | 0 |
Dry skin | 3 (10) | 0 |
Rash | 2 (6.7) | 0 |
Palmar-plantar erythrodysesthesia syndrome | 1 (3.3) | 0 |
Skin irritation | 1 (3.3) | 0 |
Small intestinal obstruction | 0 | 1 (3.3) |
Colitis | 0 | 1 (3.3) |
Acute kidney injury | 0 | 1 (3.3) |